Toward a Comparative Overview of Dependence Potential and Acute Toxicity of Psychoactive Substances Used Nonmedically

References

• Eddy N. B. The National Research Council Involvement in the Opiate Problem: 1928–1971. National Academy of Sciences, Washington, D.C. 1973
   Google Scholar
• Testing for Abuse Liability of Drugs in Humans, M. W. Fischman, N. K. Mello. NIDA Research Monograph 92, U.S. Government Printing Office, Washington, D.C. 1989
   Google Scholar
• Davis W. M., Bedford J. A., Buelke J. L., et al. Acute toxicity and gross behavioral effects of amphetamines, four methoxyamphetamines, and mescaline in rodents, dogs, and monkeys. Toxicol. Appl. Pharmacol 1978; 45: 49–62
   PubMed Web of Science ®Google Scholar
• Foltin R. W., Fischman M. W. Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug Alcohol Depend 1991; 28: 3–48
   PubMed Web of Science ®Google Scholar
• Griffiths R. R., Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J. Clin. Psychopharmacol 1990; 10: 237–243
   PubMed Web of Science ®Google Scholar
• Guarino J. J., Roacher J. D., Kirk W. T., . Comparison of the behavioral effects and abuse liability of ethanol and pentobarital in recreational sedative users. Problems of Drug Dependence 1989, L. S. Harris, et al. NIDA Research Monograph 95, U.S. Government Printing Office, Washington, D.C. 1990; 453–454
   Google Scholar
• Orzack M. H., Friedman L., Dessain E., et al. Comparative study of the abuse liability of Alprazolam, Lorazepam, Diazepam, Methaqualone and placebo. Int. J. Addict 1988; 23: 449–467
   PubMed Web of Science ®Google Scholar
• Anthony J. C., Petronis K. R. Cocaine and heroin dependence compared: Evidence from an epidemiological field survey. Am. J. Public Health 1989; 79: 1409–1410
   PubMed Web of Science ®Google Scholar
• Goldstein A., Kalant H. Drug policy: Striking the right balance. Science 1990; 249: 1513–1521
   PubMed Web of Science ®Google Scholar
• Haertzen C. A., Kocher T. R., Miyasato K. Reinforcements for the first drug experience can predict later drug habits and/or addiction: Results with coffee, cigarettes, alcohol, barbiturate, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. Drug Alcohol Depend 1983; 11: 147–165
   PubMed Web of Science ®Google Scholar
• Hammersley R., Forsyth A., Morrison V. Objective and subjective aspects of addiction: Cigarettes, alcohol, cannabis and heroin compared. Br. J. Addict 1988; 83: 1472, (abstr.)
   Google Scholar
• Iwamoto E., Martin W. A critique of drug self‐administration as a method for predicting abuse potential of drugs. Problems of Drug Dependence, L. S. Harris. NIDA Research Monograph 81, U.S. Government Printing Office, Washington, D.C. 1988; 457–465
   Google Scholar
• Jasinski D. R., Henningfield J. E. Human abuse liability assessment by measurement of subjective and physiological effects. Testing for Abuse Liability of Drugs in Humans, M. W. Fischman, N. K. Mello. NIDA Research Monograph 92, U.S. Government Printing Office, Washington, D.C. 1989; 73–100
   Google Scholar
• Kozlowski T., Wilkinson A., Skinner W., et al. Comparing tobacco cigarette dependence with other drug dependencies. J. Am. Med. Assoc 1989; 26: 898–901
   Google Scholar
• Lukas S. E., Mendelson J. H., Amass L., . Behavioral and EEG studies of acute cocaine administration: Comparisons with morphine, amphetamine, pentobarbital, nicotine, ethanol and marijuana. Problems of Drug Dependence 1989, L. S. Harris, et al. NIDA Research Monograph 95, U.S. Government Printing Office, Washington, D.C. 1990; 146–151
   Google Scholar
• Mello N. K., Mendelson J. H. Operant analysis of human self‐administration: Marijuana, alcohol, heroin, and polydrug use. Methods of Assessing the Reinforcing Properties of Abused Drugs, M. A. Bozarth. Springer‐Verlag, New York 1987; 522–572
   Google Scholar
• Zablik J. E., Roache J. D., Johnson W., et al. Dependence liability of caffeine, cocaine, nicotine and phencyclidine. Res. Commun. Substances Abuse 1983; 4: 93–95
   Google Scholar
• Brady J. V., Lukas S. E. Testing Drugs for Physical Dependence Potential and Abuse Liability. NIDA Research Monograph 52, U.S. Government Printing Office, Washington, D.C. 1984
   Google Scholar
• Methods of Assessing the Reinforcing Properties of Abused Drugs, M. A. Bozarth. Springer‐Verlag, New York 1987
   Google Scholar
• Goldberg S. R., Stolerman I. P. Behavioral Analysis of Drug Dependence. Academic Press, London 1986
   Google Scholar
• Johanson C. E., Schuster C. R. Animal models of self‐administration. Advances in Substance Abuse: Behavioral and Biological Research, N. K. Mello. JAI Press, Greenwich, Connecticut 1981; 219–297
   Google Scholar
• Self‐Administration of Abused Substances: Methods for Study, N. A. Krasnegor. NIDA Research Monograph 20, U.S. Government Printing Office, Washington, D.C. 1978
   Google Scholar
• Sanger D. J. Screening for abuse and dependence liabilities. Behavioural Models in Psychopharmacology: Theoretical, Industrial, and Clinical Perspectives, P. Willner. Cambridge University Press, Cambridge 1991; 485–502
   Google Scholar
• Haertzen C. A., Hickey J. E. Addiction Research Center Inventory (ARCI): Measurement of euphoria and other drug effects. Methods of Assessing the Reinforcing Properties of Abused Drugs, M. A. Bozarth. Springer‐Verlag, New York 1987; 489–524
   Google Scholar
• Smart R. G. Grack cocaine use: A review of prevalence and adverse effects. Am. J. Drug Alcohol Abuse 1991; 17: 13–26
   PubMed Web of Science ®Google Scholar
• Angel Dust: An Ethnographic Study of PCP Users, H. W. Feldman, M. H. Aga, G. M. Beschner. Lexington Books, Lexington, Massachusetts 1979
   Google Scholar
• Jaffe J. H., Jaffe F. K. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. Testing for Abuse Liability of Drugs in Humans, M. W. Fischman, N. K. Mello. NIDA Research Monograph 92, U.S. Government Printing Office, Washington, D.C. 1989; 43–72
   Google Scholar
• Fischman M. W. Cocaine and the amphetamines. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1543–1552
   Google Scholar
• Gawin F. H., Ellinwood E. H. Cocaine dependence. Ann. Rev. Med 1989; 40: 149–161
   PubMed Web of Science ®Google Scholar
• Woolverton W. L., Kleven M. S. Evidence for cocaine dependence in monkeys following a prolonged period of exposure. Psychopharmacology 1988; 94: 288–291
   PubMed Web of Science ®Google Scholar
• Jones R. T. Tobacco dependence. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1589–1595
   Google Scholar
• Griffiths R. R., Sannerud C. A. Abuse of and dependence on benzodiazepines and other anxiolytic/sedative drugs. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1536–1542
   Google Scholar
• Bourgois P. In search of Horatio Alger: Culture and ideology in the crack economy. Contemp. Drug Probl 1989; 16: 619–650
   Google Scholar
• Rounsaville B. J., Spitzer R. L., Williams J. B. W. Proposed changes in DSM‐III substance use disorders: Description and rationale. Am. J. Psychiatry 1986; 143: 463–468
   PubMed Web of Science ®Google Scholar
• Nies A. S. Principles of therapeutics. Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 618–630
   Google Scholar
• Johanson C. E., Woolverton W. L., Schuster C. R. Evaluating laboratory models of drug dependence. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1617–1625
   Google Scholar
• Hardman H. F., Haavik C. O., Seavers M. H. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals. Toxicity Appl. Pharmacol 1973; 25: 299
   PubMed Web of Science ®Google Scholar
• Logan B. J., Laverty R., Sanderson W. D., et al. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur. J. Pharmacol 1988; 152: 227–234
   PubMed Web of Science ®Google Scholar
• Martin W. R. The nature of opioid and LSD receptors: Structural activity relationship implications. QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists and Hallucinogens, G. Barnett, M. Trsic, R. Willette. NIDA Research Monograph 22, U.S. Government Printing Office, Washington, D.C. 1978; 60–67
   Google Scholar
• Bruce R. D. A confirmatory study of the up‐and‐down method for acute oral toxicity testing. Fundam. Appl. Toxicol 1987; 8: 97–100
   PubMedGoogle Scholar
• Goldberg A. M., Frazier J. M. Alternatives to animals in toxicity testing. Sci. Am 1989; 261: 24–30
   PubMed Web of Science ®Google Scholar
• Froede S. W., Byers J. M., Wolfgang G. S., et al. An analysis of toxic deaths, 1982–1985, Pima County, Arizona. J. Forensic Sci 1987; 32: 1676–1693
   PubMed Web of Science ®Google Scholar
• Chadly A., Marc B., Barres D., et al. Suicide by nitrous oxide poisoning. Am. J. Forensic Med. Pathol 1989; 10: 330–331
   PubMed Web of Science ®Google Scholar
• Fraser A. D., Isner A. F., Moss M. A. A fatality involving clomipramine. J. Forensic Sci 1986; 31: 762–765
   PubMed Web of Science ®Google Scholar
• Sperry K., Sweeney E. S. Suicide by intravenous injection of cocaine: A report of three cases. J. Forensic Sci 1989; 34: 244–248
   PubMed Web of Science ®Google Scholar
• Introna F., Smialek J. E. The “mini‐packer” syndrome: Fatal ingestion of drug containers in Baltimore, Maryland. Am. J. Forensic Med. Pathol 1989; 10: 21–24
   PubMed Web of Science ®Google Scholar
• Kramer L. D., Locke G. E., Ogunyemi A., et al. Cocaine‐related seizures in adults. Am. J. Drug Alcohol Abuse 1990; 16: 309–317
   Web of Science ®Google Scholar
• Allen J. W. A private inquiry into the circumstances surrounding the 1972 death of John Gomill, Jr., who died after allegedly consuming ten hallucinogenic mushrooms while residing in Hawaii. J. Psychoactive Drugs 1988; 20: 451–454
   PubMed Web of Science ®Google Scholar
• Bal T. S., Gutteridge D. R., Johnson B., et al. Adverse effects of the use of unusual phenethylamine compounds sold as illicit amphetamine. Med. Sci. Law 1989; 29: 186–188
   PubMed Web of Science ®Google Scholar
• Shannon M. Clinical toxicity of cocaine adulterants. Ann. Emerg. Med 1988; 17: 1243–1247
   PubMed Web of Science ®Google Scholar
• DAWN (Drug Abuse Warning Netowrk). Emergency Room Mentions. National Institute on Drug Abuse, Rockville, Maryland 1988
   Google Scholar
• Anthony J. C., Trinkoff A. M. U.S. Epidemiologic data on drug use and abuse: How are they relevant to testing abuse liability of drug?. Testing for Abuse Liability in Humans, M. Fischman, N. K. Mello. NIDA Research Monograph 92, U.S. Government Printing Office, Washington, D.C. 1989; 241–266
   Google Scholar
• Lincoln Y. S., Guba E. G. Naturalistic Inquiry. Sage Publications, Beverly Hills, California 1985
   Google Scholar
• Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990
   Google Scholar
• Ellenhorn M. J., Barceloux D. G. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. Elsevier, New York 1988
   Google Scholar
• Julian R. M. A Primer of Drug Action5th ed. Freeman, New York 1988
   Google Scholar
• Meltzer H. Y. Psychopharmacology: The Third Generation of Progress. Raven Press, New York 1987
   Google Scholar
• Abel E. L. A Comprehensive Guide to the Cannabis Literature. Greenwood Press, Westport, Connecticut 1979
   Google Scholar
• Andrews T. A Bibliography of Drug Abuse: Supplement 1977–1980. Libraries Unlimited, Littleton, Colorado 1981
   Google Scholar
• Snow B. Drug Information: A Guide to Current Resources. Medical Library Association, Chicago 1989
   Google Scholar
• Turner C. E., Urbanek B. S., Wall G. M., et al. Cocaine: An Annotated Bibliography. University Press of Mississippi, Jackson, Mississippi 1988
   Google Scholar
• Snyder C. A., Wood R. W., Graefe J. F., et al. “Crack smoke” is a respirable aerosol of cocaine base. Pharmacol. Biochem. Behav 1988; 29: 93–95
   PubMed Web of Science ®Google Scholar
• Wood R. W. Animal models of drug self‐administration by smoking. Research Findings on Smoking Abused Substances, C. N. Chiang, R. L. Hawks. NIDA Research Monograph 99, U.S. Government Printing Office, Washington, D.C. 1990; 159–169
   Google Scholar
• Cox C. T., Jacobs M. R., Leblanc A. E., et al. Drugs and Drug Abuse: A Reference Text. Addiction Research Foundation, Toronto 1983
   Google Scholar
• Inturrisi C. E., Max M. B., Foley K. M., et al. The pharmacokinetics of heroin in patients with chronic pain. New Engl. J. Med 1984; 310: 1213
   PubMed Web of Science ®Google Scholar
• Platt J. J. Heroin Addiction: Theory, Research, and Treatment2nd ed. Krieger, Malabar, Florida 1986
   Google Scholar
• Strang J. Lessons from an English opium eater: Thomas de Quincey reconsidered. Int. J. Addict 1990; 25: 1455–1465
   PubMed Web of Science ®Google Scholar
• Way E. L., Kemp J. W., Young J. M., et al. The pharmacologic effects of heroin in relationship to its rate of biotransformation. J. Pharmacol. Exp. Ther 1960; 129: 144–154
   PubMed Web of Science ®Google Scholar
• Preston K. L., Jasinski D. R. Abuse liability studies of opioid agonist‐antagonists in humans. Drug Alcohol Depend 1991; 28: 49–82
   PubMed Web of Science ®Google Scholar
• Jaffe J. H., Martin W. R. Opioid analgesics and antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 485–501
   Google Scholar
• Ray O. R., Ksir C. Drugs, Society, and Human Behavior4th ed. Times Mirror/Mosby, St Louis, Missouri 1990
   Google Scholar
• Blackwell J. S. Opiate dependence as a psychological event: Users' reports of subjective experience. Contemp. Drug Probl 1985; 12: 331–350
   Google Scholar
• Brecher E. Little, Brown & Co., Boston, Massachusetts 1972, Editors of Consumer Reports, Licit and Illicit Drugs
   Google Scholar
• Edwards G. Opium and after. Lancet February 16, 1980; 351: 1
   Google Scholar
• Isbell H. Opium poisoning. Textbooks of Medicine11th ed., P. B. Beeson, W. McDermott. Saunders, Philadelphia 1963; 1744–1749
   Google Scholar
• Westermeyer J. Poppies, Pipes, and People. University of California Press, Berkeley, California 1982
   Google Scholar
• Arena J. M., Drew R. H. Poisoning5th ed. Thomas, Springfield, Illinois 1986
   Google Scholar
• Sellers E. M. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: Clinical management. Can. Med. Assoc. J 1988; 139: 113–120
   PubMed Web of Science ®Google Scholar
• Tracqui A., Kintz P., Mangin P., et al. A fatality involving secobarbital, nitrazepam, and codeine. Forensic Toxicol 1989; 10: 130–133
   Google Scholar
• Ashton H. Protracted withdrawal syndromes from benzodiazepines. J. Substance Abuse Treatment 1991; 8: 19–28
   PubMed Web of Science ®Google Scholar
• de Wit H., Griffiths R. R. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 1991; 28: 81–111
   Web of Science ®Google Scholar
• Miller N. S., Gold M. S. Benzodiazepines: Tolerance, dependence, abuse, and addiction. J. Psychoactive Drugs 1990; 22: 23–33
   PubMed Web of Science ®Google Scholar
• Rosenthal S. A., Girgenti A. J., Brown M. T. Apparent diazepam toxicity in a child due to accidental ingestion of misrepresented quaalude. Vet. Human Toxicol 1984; 26: 320–321
   PubMedGoogle Scholar
• Heishman S. J., Stitzer M. L., Bigelow G. E. Alcohol and marijuana: Comparative dose effect profiles in humans. Pharmacol. Biochem. Behav 1989; 31: 649–655
   Web of Science ®Google Scholar
• Kaim S. C., Klett C. J., Rothfeld B. Treatment of the acute alcohol withdrawal state: A comparison of four drugs. Am. J. Psychiatry 1969; 125: 1640–1646
   PubMed Web of Science ®Google Scholar
• Rall T. W. Hypnotics and sedatives; ethanol. Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. P. Nies, P. Taylor. Pergamon Press, New York 1990; 360–383
   Google Scholar
• Wallgren H., Barry H. Actions of Alcohol. Elsevier, Amsterdam 1970; Vol. 2
   Google Scholar
• Wimer W., Russlee J. A., Kaplan H. L. Alcohols Toxicology. Noyes Data Corp., Park Ridge, New Jersey 1983
   Google Scholar
• Ionescu‐Pioggia M., Bird M., Cole J. O. Subjective effects of methaqualone. Problems of Drug Dependence 1989, L. S. Harris. NIDA Research Monograph 95, U.S. Government Printing Office, Washington, D.C. 1990; 454–455
   Google Scholar
• Litovitz L. T. Methaqualone. Poisoning and Drug Overdose, L. M. Haddad, F. J. Winchester. Sanders, Philadelphia 1973; 466–467
   Google Scholar
• Martindale: The Extra Pharmacopoeia29th ed., J. E. F. Reynolds. The Pharmaceutical Press, London 1989; 751–752
   Google Scholar
• Huff J. S. Amphetamines/stimulants. Manual of Toxicologic Emergencies, E. K. Noji, G. D. Kelen. Year Book Medical Publishers, Chicago 1988; 350–355
   Google Scholar
• Seiden L. S., Ricurte G. S. Neurotoxicity of methamphetamine and related drugs. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1988; 360–371
   Google Scholar
• Abbott P. J. Caffeine: A toxicological overview. Med. J. Aust 1986; 145: 518–521
   PubMed Web of Science ®Google Scholar
• Griffiths R. R., Woodson P. P. Caffeine physical dependence: A review of human and laboratory animal studies. Psychopharmacologia 1988; 94: 437–451
   PubMed Web of Science ®Google Scholar
• Rall T. W. Drugs used in the treatment of asthma. Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. S. Nies. Taylor, Pergamon Press, New York 1990; 618–637
   Google Scholar
• Stavric B. Methylxanthines: Toxicity to humans. 2. Caffeine. Food Chem. Toxicol 1988; 26: 645–662
   PubMed Web of Science ®Google Scholar
• Stern K. N., Chait L. D., Johanson C. E. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology 1989; 98: 81–88
   PubMed Web of Science ®Google Scholar
• Johanson C. E., Fischman M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev 1989; 41: 3–44
   PubMed Web of Science ®Google Scholar
• Jones R. T. The pharmacology of cocaine. Cocaine: Pharmacology, Effects, and Treatment of Abuse, J. Grabowski. NIDA Research Monograph 50, U.S. Government Printing Office, Washington, D.C. 1984; 34–49
   Google Scholar
• Smart E. G., Anglin L. Do we know the lethal dose of cocaine?. J. Forensic Sci 1987; 32: 303–311
   PubMed Web of Science ®Google Scholar
• Cheug Y. W., Erickson P. G., Landau T. C. Experience of crack use: Findings from a community‐based sample in Toronto. J. Drug Issues 1991; 21: 121–140
   Web of Science ®Google Scholar
• Ettinger N. A., Albin R. J. A review of the respiratory effects of smoking cocaine. Am. J. Med 1989; 87: 664–668
   PubMed Web of Science ®Google Scholar
• Jones R. T. The pharmacology of cocaine smoking in humans. Research Findings on Smoking of Abused Substances, C. N. Chaing, R. L. Hawks. NIDA Research Monograph 99, U.S. Government Printing Office, Washington, D.C. 1990; 30–41
   Google Scholar
• Perez‐Reyes M., DiGuiseppe S., Ondrusek G., et al. Free‐base cocaine smoking. Clin. Pharmacol. Ther 1982; 32: 459–467
   PubMed Web of Science ®Google Scholar
• Henningfield J. E. Pharmacologic basis and treatment of cigarette smoking. Clin. Psychiatry 1984; 45: 24–33
   PubMed Web of Science ®Google Scholar
• Saxena K., Scheman A. Suicide plan by nicotine poisoning: A review of nicotine toxicity. Vet. Human Toxicol 1985; 27: 495–497
   PubMedGoogle Scholar
• Warburton D. M. The puzzle of nicotine use. The Psychopharmacology of Addiction, M. Lader. Oxford University Press, Oxford 1988; 27–49
   Google Scholar
• Hansen G., Jensen S. B., Chandresh L., et al. The psychotropic effect of ketamine. J. Psychoactive Drugs 1988; 20: 419–425
   PubMed Web of Science ®Google Scholar
• Faithfull N. S., Poelman K. M., Erdmann W. Ketamine‐induced dysrhythmia and its antagonism: A case report. Eur. J. Anaethesiol 1987; 4: 287–291
   PubMed Web of Science ®Google Scholar
• Hodgson E., Mailman R. B., Chambers J. E. Dictionary of Toxicology. Van Nostrand Reinhold, New York 1980
   Google Scholar
• Jansen K. L. R. Ketamine–Can chronic use impair memory?. Int. J. Addict 1990; 25: 133–139
   PubMed Web of Science ®Google Scholar
• Rogo D. S. Ketamine and the near‐death experience. Anabiosis 1984; 4: 87–96
   Google Scholar
• Danton W. G., May J. R., Lynn E. J. Psychological and physiological effects of relaxation and nitrous oxide training. Psychol. Rep 1984; 55: 311–322
   PubMed Web of Science ®Google Scholar
• Daynes G. The initial management of alcoholism using oxygen and nitrous oxide: A transcultural study. Int. J. Neurosci 1989; 49: 83–86
   PubMed Web of Science ®Google Scholar
• Block R. L., Ghoneim M. W., Kumar V., et al. Psychedelic effects of a subanesthetic concentration of nitrous oxide. Anesth. Prog 1990; 37: 271–276
   PubMedGoogle Scholar
• Enticknap J. B. A case of fatal accidental N2O poisoning. Med. Sci. Law 1961; 1: 404–409
   Google Scholar
• Layzer R. B. Nitrous oxide abuse. Nitrous Oxide, E. I. Eger. Elsevier, New York 1985; 251–257
   Google Scholar
• Aniline O., Pitts F. N. Phencyclindines (PCP): A review and perspectives. CRC Crit. Rev. Toxicol April, 1982; 145–177
   Google Scholar
• Blaster R. The behavioral pharmacology of phencyclidine. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1573–1755
   Google Scholar
• Burns R. S., Lerner S. E. Causes of phencyclidine‐related deaths. Clin. Toxicol 1978; 12: 463–481
   PubMed Web of Science ®Google Scholar
• McCarron M. M. Phencyclidine intoxication. Phencyclidine: An Update, D. H. Clouet. NIDA Research Monograph 64, U.S. Government Printing Office, Washington, D.C. 1986; 214–217
   Google Scholar
• Poklis A., Graham M., Maginn D. Phencyclidine and violent deaths in St. Louis, Missouri: A survey of medical examiners' cases from 1977 through 1986. Am. J. Drug Alcohol Abuse 1990; 16: 265–274
   PubMed Web of Science ®Google Scholar
• Fysh R. R., Oon M. C. H., Robinson K. N., et al. A fatal poisoning with LSD. Forensic Sci. Int 1985; 28: 109–113
   PubMed Web of Science ®Google Scholar
• Jaffe J. H. Drug addiction and drug abuse. Goodman and Gilman's The Pharmacological Basis of Therapeutics8th ed., A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 522–572
   Google Scholar
• Klock J. C., Boerner U., Becker C. E. Coma, hyperthermia, and bleeding associated with massive LSD overdose: A report of eight cases. West. J. Med 1973; 120: 183–188
   Google Scholar
• Litovitz L. T., Hallucinogens. Poisoning and Drug Overdose, L. M. Haddad, J. F. Winchester. Sanders, Philadelphia 1983; 459
   Google Scholar
• Strassman R. J. Adverse reactions to psychedelic drugs: A review of the literature. J. Nerv. Ment. Disorders 1984; 172: 577–593
   PubMed Web of Science ®Google Scholar
• Bost R. O. 3,4‐Methlenedioxymethamphetamine (MDMA) and other amphetamine derivatives. J. Forensic Sci 1988; 33: 576–587
   PubMed Web of Science ®Google Scholar
• Glennon R. S. Psychoactive phenylisopropylamines. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1627–1634
   Google Scholar
• McKenna D. J., Peroutka S. J. Neurochemistry and neurotoxicity of 3,4‐methylenedioxy‐methamphetamine (MDMA, “Ecstasy”). J. Neurochem 1990; 54: 14–22
   PubMed Web of Science ®Google Scholar
• Ricaurte G. A. Studies of MDMA‐induced neurotoxicity in nonhuman primates: A basis for evaluating long‐term effects in humans. Pharmacology and Toxicology of Amphetamine and Related Designer Drugs, K. Asghar, E. DeSouza. NIDA Research Monograph 94, U.S. Government Printing Office, Washington, D.C. 1989; 306–322
   Google Scholar
• Schmidt C. J. Neurotoxicity of psychedelic amphetamine, methylenedioxymethampetamine. J. Pharmacol. Exp. Ther 1987; 240: 1–6
   PubMed Web of Science ®Google Scholar
• Bergman R. L. Navajo peyote use: Its apparent safety. Am. J. Psychiatry 1971; 128: 695–699
   PubMed Web of Science ®Google Scholar
• Hoffer A., Osmond H. The Hallucinogens. Academic Press, New York 1967
   Google Scholar
• Hollister L. E. Effects of hallucinogens in humans. Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives, B. L. Jacobs. Raven Press, New York 1984; 19–27
   Google Scholar
• Mack R. B. Marching to a different cactus: Peyote (mescaline) intoxication. N. C. Med. J 1986; 47: 137–138
   PubMedGoogle Scholar
• Lincoff G., Mitchel D. H. Toxic and Hallucinogenic Mushroom Poisoning: A Handbook for Physicians and Mushroom Hunters. Van Nostrand Reinhold Co., New York 1977
   Google Scholar
• Parashos A. J. The psilocybin‐induced “state of drunkenness” in normal volunteers and schizophrenics. Behav. Neuropsychiatry 1977; 8: 83–86
   Google Scholar
• Penden N. R., Pringle S. D., Crooks J. The problem of psilocybin mushroom abuse. Human Toxicol 1982; 1: 417–424
   PubMedGoogle Scholar
• Singer R. Hallucinogenic mushrooms. Mushroom Poisoning: Diagnosis and Treatment, B. H. Rumack, E. Salzman. CRC Press, West Palm Beach, Florida 1978; 201–208
   Google Scholar
• Spoerke D. G., Hall A. H. Plants and mushrooms of abuse. Emergency Med. Clin. North Am 1990; 8: 579–593
   PubMedGoogle Scholar
• Braude M. C. Toxicology of cannabinoids. Cannabis and Its Derivatives, W. D. M. Paton, J. Crown. Oxford University Press, London 1972; 90
   Google Scholar
• Bro P., Schou J. Cannabis poisoning with analytical verification. New Engl. J. Med 1975; 293: 1049–1050
   PubMed Web of Science ®Google Scholar
• Mendelson J. H. Marijuana. Psychopharmacology: The Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 1563–1571
   Google Scholar
• Rohr J. M., Skowlund S. W., Martin T. E. Withdrawal sequelae to cannabis use. Int. J. Addict 1989; 24: 627–631
   PubMed Web of Science ®Google Scholar
• Selden B. S., Clark R. F., Curry S. C. Marijuana. Emergency Med. Clin. North Am 1990; 8: 527–539
   PubMedGoogle Scholar
• McKim W. A. Drugs and Behavior: An Introduction to Behavioral Pharmacology2nd ed. Prentice‐Hall, Englewood Cliffs, New Jersey 1991
   Google Scholar
• Revell A. D. Smoking and performance–A puff‐by‐puff analysis. Psychopharmacology 1988; 96: 563–565
   PubMed Web of Science ®Google Scholar
• Sahenk Z., Mendell J. R., Couri D., et al. Polyneuropathy from inhalation of N2O cartridges through a whipped‐cream dispenser. Neurology 1978; 28: 485–487
   PubMed Web of Science ®Google Scholar
• Chait L. D. Delta‐9‐tetrahydrocannabinol content and human marijuana self‐administration. Psychopharmacology 1989; 98: 51–55
   PubMed Web of Science ®Google Scholar
• Perez‐Reyes M. Marijuana smoking: Factors that influence the bioavailability of tetrahydrocannabinol. Research Finding on Smoking of Abused Substances, C. N. Chiang, R. L. Hawks. NIDA Research Monograph 99, U.S. Government Printing Office, Washington, D.C. 1990; 42–61
   Google Scholar
• Brady J. V., Lukas S. E., Hienz R. D. Relationship between reinforcing properties and sensory/motor toxicity of CNS depressants; Implications for the assessment of abuse liability. Problems of Drug Dependence, 1982, L. S. Harris. NIDA Research Monograph 43, U.S. Government Printing Office, Washington, D.C. 1983; 196–202
   Google Scholar
• Brady J. V., Griffiths R. R., Hienz R. D., . Assessing drugs for abuse liability and dependence potential in laboratory primates. Methods of Assessing the Reinforcing Properties of Abused Drugs, M. A. Bozarth, et al. Springer‐Verlag, New York 1987; 45–84
   Google Scholar
• National Institute on Alcohol Abuse and Alcoholism, Announcement. Research on the recognition, management, and prevention of alcohol problems in a primary health care setting. 1990, Cat. Fed. Domest. Assist No. 13.273
   Google Scholar
• Erickson P. G., Alexander B. K. Cocaine and addictive liability. Soc. Pharmacol 1989; 3: 249–270
   Google Scholar
• Siegel R. K. Changing patterns of cocaine use: Longitudinal observations, consequences, and treatment. Cocaine: Pharmacology, Effects, and Treatment of Abuse, J. Grabowski. NIDA Research Monograph 50, U.S. Government Printing Office, Washington, D.C. 1984; 93–109
   Google Scholar
• National Research Council. Commission on Life Sciences, Committee on the Institutional Means for Assessment of Risks to Public Health. Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, D.C. 1983
   Google Scholar